Filter posts

BIO Mourns Passing of Dr. John Holaday

On behalf of the team at BIO, we send our deepest condolences to the family …

Welcome to #BIO2019

As BIO’s President and CEO, who proudly represented the Philadelphia suburbs in Congress for 12 …

Why Concerns About a “Break Down” in Drug Pricing Are Misplaced

Just moments after it was announced the FDA had approved a new treatment for spinal …

Dr. Emanuel Misses the Mark with Latest Industry Attack

Writing for The Atlantic, Dr. Ezekiel Emanuel accuses the biopharmaceutical industry of being “deceptive” when …

Why We Need Innovation in Food and Agriculture

Two of our most beloved breakfast beverages — coffee and orange juice — are under …

Latest Measles Outbreak is a Crash Course on the Importance of Immunization

It’s hard to miss the news coming from the Pacific Northwest. Every major media outlet …

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

The biotech industry recently realized its 300th IPO since the Jumpstart Our Business Startups (JOBS) …

Medical Research from Mars Can Fail Patients from Venus

Historically, federal dollars inadvertently flowed to medical research with a disproportionate focus on men’s health. …

BIO Latin America to Showcase Brazil’s Agricultural Breakthroughs

Brazil’s vast, fertile landscape – covering 47 percent of the South American continent – is …

Senate Has the Power to Expand Access to Medication for Opioid Addiction

BIO President and CEO Jim Greenwood posted the following op-ed on Linked-In today, making the …